Simple Summary The poor prognosis of pancreatic cancer (PC) is associated with several
factors, such as diagnosis at an advanced stage, early distant metastases, and remarkable …

Renal cell carcinoma (RCC) is the third most common genitourinary cancer accounting for
approximately 180,000 deaths worldwide in 2020. Although over two-thirds of patients …

Background: YouTubeTM is an open-access source for mass information. Several previous
studies of YouTubeTM videos showed a high rate of misinformation in the urological field …

Renal cell carcinoma (RCC) is the most common renal malignancy with a rapidly increasing
morbidity and mortality rate gradually. RCC has a high mortality rate and an extremely poor …

Background Microbiome dysbiosis is considered a predictive biomarker of clinical response
in renal cell carcinoma (RCC), which can be regulated by antibiotics (ATB). Multiple studies …

Background and aims Immune checkpoint inhibitors (ICI) cause acute gastrointestinal (GI)
immune-related adverse events (IrAEs). We aimed to report and describe chronic GI IrAEs …

Patients with high-risk non-metastatic renal cell carcinoma (RCC) are at risk of metastatic
relapse following nephrectomy. Cabozantinib (CZ), a potent multitarget tyrosine kinase …

Renal cell carcinoma with level IV tumor thrombus is a condition necessitating aggressive
surgical management. Many solid organ malignancies often benefit from neoadjuvant …

Simple Summary Despite a significant improvement in clinical outcomes and the emergence
of novel and potentially curative strategies, a noticeable number of oncological patients …

Background In the past few years, there has been a continuous rise in the occurrence of
renal cell carcinoma (RCC), with RCC recurrence becoming the primary factor behind …